BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38018100)

  • 1. Heterogeneity in killing efficacy of individual effector CD8
    Bera S; Amino R; Cockburn IA; Ganusov VV
    Proc Biol Sci; 2023 Nov; 290(2011):20232280. PubMed ID: 38018100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected mice.
    Cabrera M; Pewe LL; Harty JT; Frevert U
    PLoS One; 2013; 8(8):e70842. PubMed ID: 23967119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustering of Activated CD8 T Cells Around Malaria-Infected Hepatocytes Is Rapid and Is Driven by Antigen-Specific Cells.
    Kelemen RK; Rajakaruna H; Cockburn IA; Ganusov VV
    Front Immunol; 2019; 10():2153. PubMed ID: 31616407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.
    Butler NS; Schmidt NW; Harty JT
    J Immunol; 2010 Mar; 184(5):2528-38. PubMed ID: 20097864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection.
    Kimura K; Kimura D; Matsushima Y; Miyakoda M; Honma K; Yuda M; Yui K
    Infect Immun; 2013 Oct; 81(10):3825-34. PubMed ID: 23897612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen export during liver infection of the malaria parasite augments protective immunity.
    Montagna GN; Beigier-Bompadre M; Becker M; Kroczek RA; Kaufmann SH; Matuschewski K
    mBio; 2014 Jul; 5(4):e01321-14. PubMed ID: 25073641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses.
    Doll KL; Pewe LL; Kurup SP; Harty JT
    J Immunol; 2016 May; 196(10):4253-62. PubMed ID: 27084099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.
    Billman ZP; Kas A; Stone BC; Murphy SC
    Malar J; 2016 Apr; 15():238. PubMed ID: 27113469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cells eliminate liver-stage Plasmodium berghei parasites without detectable bystander effect.
    Cockburn IA; Tse SW; Zavala F
    Infect Immun; 2014 Apr; 82(4):1460-4. PubMed ID: 24421043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8
    Spencer AJ; Longley RJ; Gola A; Ulaszewska M; Lambe T; Hill AV
    J Immunol; 2017 Mar; 198(5):2006-2016. PubMed ID: 28087668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium-host interactions directly influence the threshold of memory CD8 T cells required for protective immunity.
    Schmidt NW; Butler NS; Harty JT
    J Immunol; 2011 May; 186(10):5873-84. PubMed ID: 21460205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the Immunodominant CD8
    Gibbins MP; Müller K; Glover M; Liu J; Putrianti ED; Bauza K; Reyes-Sandoval A; Matuschewski K; Silvie O; Hafalla JCR
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii.
    Doll KL; Butler NS; Harty JT
    Vaccine; 2014 Jan; 32(4):483-91. PubMed ID: 24321740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites.
    Schmidt NW; Butler NS; Badovinac VP; Harty JT
    PLoS Pathog; 2010 Jul; 6(7):e1000998. PubMed ID: 20657824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profiling.
    Hafalla JC; Bauza K; Friesen J; Gonzalez-Aseguinolaza G; Hill AV; Matuschewski K
    PLoS Pathog; 2013 May; 9(5):e1003303. PubMed ID: 23675294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nitric oxide interrupts the accumulation of CD8+ T cells surrounding Plasmodium berghei-infected hepatocytes.
    Scheller LF; Green SJ; Azad AF
    Infect Immun; 1997 Sep; 65(9):3882-8. PubMed ID: 9284167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells.
    Nganou-Makamdop K; van Gemert GJ; Arens T; Hermsen CC; Sauerwein RW
    PLoS One; 2012; 7(5):e36508. PubMed ID: 22563506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSP--a model for in vivo presentation of Plasmodium berghei sporozoite antigens by hepatocytes.
    Balam S; Romero JF; Bongfen SE; Guillaume P; Corradin G
    PLoS One; 2012; 7(12):e51875. PubMed ID: 23272182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.